TABLE II.
All regimens | INSTI | NNRTI | PI | |||||
---|---|---|---|---|---|---|---|---|
Independent variables | Predicted change | P value | Predicted change | P value | Predicted change | P value | Predicted change | P value |
Baseline BMI <25 | ||||||||
Time | 0.51 | .000 | 0.54 | .000 | 0.48 | .000 | 0.54 | .001 |
Age | 0.03 | .067 | 0.06 | .052 | 0.02 | .369 | −0.14 | .100 |
Race/ethnicity (ref. White) | ||||||||
African American | 0.27 | .298 | 0.45 | .244 | 0.16 | .665 | −0.35 | .571 |
Other | 0.21 | .505 | −0.12 | .788 | 0.23 | .608 | 0.60 | .262 |
CD4 (ref. <500 cells/µL) | ||||||||
CD4 ≥ 500 | −0.31 | .205 | −0.25 | .443 | −0.43 | .274 | 0.88 | .191 |
Viral load (ref. <100,000 c/mL) | ||||||||
Viral load ≥100,000 | −0.33 | .187 | −0.3 | .392 | 0.16 | .659 | −1.91 | .000 |
Time from HIV diagnosis to ART start | −0.02 | .776 | −0.03 | .770 | 0.01 | .905 | 0.02 | .386 |
Anchor class (ref. INSTI) | ||||||||
NNRTI or PI | −0.15 | .515 | - | - | - | - | - | - |
Baseline BMI ≥25 | ||||||||
Time | 0.29 | .000 | 0.54 | .000 | 0.10 | .211 | 0.39 | .006 |
Age | 0.10 | .000 | 0.12 | .004 | 0.09 | .008 | 0.07 | .293 |
Race/ethnicity (ref. White) | ||||||||
African American | 0.99 | .016 | 1.85 | .007 | 0.50 | .358 | 1.53 | .186 |
Other | 0.52 | .249 | 0.89 | .228 | 0.36 | .572 | 1.95 | .086 |
CD4 (ref. <500 cells/µL) | ||||||||
CD4 ≥ 500 | 0.64 | .079 | 0.98 | .083 | 0.25 | .627 | 0.00 | .999 |
Viral load (ref. <100,000 c/mL) | ||||||||
Viral load ≥100,000 | −0.43 | .297 | −0.31 | .702 | −0.69 | .202 | 1.50 | .119 |
Time from HIV diagnosis to ART start | 0.09 | .139 | 0.34 | .005 | 0.00 | .908 | 0.44 | .037 |
Anchor class (ref. INSTI) | ||||||||
NNRTI or PI | −0.65 | .070 | - | - | - | - | - | - |
Abbreviations: ART, antiretroviral therapy; BMI, body mass index; cells/uL, cells per microliter; c/mL, copies per milliliter; INSTI, integrase strand transfer inhibitor; NNRTI, non-nucleotide reverse transcriptase inhibitor; PI, protease inhibitor.